-
1
-
-
0004633993
-
-
World Health Organization. last accessed on 6 December
-
World Health Organization. World health organization mortality database. Available from: www.who.int/healthinfo/mortality-data/en/, last accessed on 6 December 2016.
-
(2016)
World Health Organization Mortality Database
-
-
-
2
-
-
84946866065
-
Disease-modifying treatments for multiple sclerosis - A review of approved medications
-
Torkildsen, Ø., Myhr, K.-M., and Bø, L. (2016) Disease-modifying treatments for multiple sclerosis-a review of approved medications Eur. J. Neurol. 23, 18-27 10.1111/ene.12883
-
(2016)
Eur. J. Neurol.
, vol.23
, pp. 18-27
-
-
Torkildsen, Ø.1
Myhr, K.-M.2
-
3
-
-
77955618678
-
Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment
-
Braley, T. J. and Chervin, R. D. (2010) Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment Sleep 33, 1061-1067
-
(2010)
Sleep
, vol.33
, pp. 1061-1067
-
-
Braley, T.J.1
Chervin, R.D.2
-
4
-
-
84859179884
-
Multiple Sclerosis Review
-
Goldenberg, M. M. (2012) Multiple Sclerosis Review Pharm. Ther. 37, 175-184
-
(2012)
Pharm. Ther.
, vol.37
, pp. 175-184
-
-
Goldenberg, M.M.1
-
5
-
-
79960989910
-
Multiple Sclerosis: Pathogenesis and Treatment
-
Loma, I. and Heyman, R. (2011) Multiple Sclerosis: Pathogenesis and Treatment Curr. Neuropharmacol. 9, 409-416 10.2174/157015911796557911
-
(2011)
Curr. Neuropharmacol.
, vol.9
, pp. 409-416
-
-
Loma, I.1
Heyman, R.2
-
6
-
-
84893062631
-
Dimethyl fumarate for treatment of multiple sclerosis: Mechanism of action, effectiveness, and side effects
-
Linker, R. A. and Gold, R. (2013) Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects Curr. Neurol. Neurosci. Rep. 13, 394 10.1007/s11910-013-0394-8
-
(2013)
Curr. Neurol. Neurosci. Rep.
, vol.13
, pp. 394
-
-
Linker, R.A.1
Gold, R.2
-
7
-
-
84921047168
-
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: An overview
-
Bomprezzi, R. (2015) Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview Ther. Adv. Neurol. Disord. 8, 20-30 10.1177/1756285614564152
-
(2015)
Ther. Adv. Neurol. Disord.
, vol.8
, pp. 20-30
-
-
Bomprezzi, R.1
-
8
-
-
34547129333
-
Treatment of psoriasis with fumaric acid esters (Fumaderm)
-
Mrowietz, U., Altmeyer, P., Bieber, T., Röcken, M., Schopf, R. E., and Sterry, W. (2007) Treatment of psoriasis with fumaric acid esters (Fumaderm) J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG 5, 716-717 10.1111/j.1610-0387.2007.06346.x
-
(2007)
J. Dtsch. Dermatol. Ges. J. Ger. Soc. Dermatol. JDDG
, vol.5
, pp. 716-717
-
-
Mrowietz, U.1
Altmeyer, P.2
Bieber, T.3
Röcken, M.4
Schopf, R.E.5
Sterry, W.6
-
9
-
-
84897969927
-
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
-
Ruggieri, S., Tortorella, C., and Gasperini, C. (2014) Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis Ther. Clin. Risk Manage. 10, 229-239 10.2147/TCRM.S53285
-
(2014)
Ther. Clin. Risk Manage.
, vol.10
, pp. 229-239
-
-
Ruggieri, S.1
Tortorella, C.2
Gasperini, C.3
-
10
-
-
85018483803
-
Brain Delivery by Oral Nanoparticles: Promises, Challenges and Future Prospects
-
M/s Studium Press LLC, USA, Houston, TX
-
Kumar, P., Malik, R., and Raza, K. Brain Delivery by Oral Nanoparticles: Promises, Challenges and Future Prospects. In NanoBioMedicine, M/s Studium Press LLC, USA, Houston, TX, 2016.
-
(2016)
NanoBioMedicine
-
-
Kumar, P.1
Malik, R.2
Raza, K.3
-
11
-
-
70449529433
-
Structure and function of the blood-brain barrier
-
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., and Begley, D. J. (2010) Structure and function of the blood-brain barrier Neurobiol. Dis. 37, 13-25 10.1016/j.nbd.2009.07.030
-
(2010)
Neurobiol. Dis.
, vol.37
, pp. 13-25
-
-
Abbott, N.J.1
Patabendige, A.A.K.2
Dolman, D.E.M.3
Yusof, S.R.4
Begley, D.J.5
-
12
-
-
57649136406
-
Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS
-
Silva, G. A. (2008) Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS BMC Neurosci. 9, S4 10.1186/1471-2202-9-S3-S4
-
(2008)
BMC Neurosci.
, vol.9
, pp. S4
-
-
Silva, G.A.1
-
13
-
-
84984809120
-
Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review
-
Kumar, P., Raza, K., Kaushik, L., Malik, R., Arora, S., and Katare, O. P. (2016) Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review Curr. Pharm. Des. 22, 5127-5143 10.2174/1381612822666160524144926
-
(2016)
Curr. Pharm. Des.
, vol.22
, pp. 5127-5143
-
-
Kumar, P.1
Raza, K.2
Kaushik, L.3
Malik, R.4
Arora, S.5
Katare, O.P.6
-
14
-
-
84992151588
-
Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences
-
Kumar, P., Sharma, G., Kumar, R., Singh, B., Malik, R., Katare, O. P., and Raza, K. (2016) Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences Int. J. Pharm. 515, 307-314 10.1016/j.ijpharm.2016.10.024
-
(2016)
Int. J. Pharm.
, vol.515
, pp. 307-314
-
-
Kumar, P.1
Sharma, G.2
Kumar, R.3
Singh, B.4
Malik, R.5
Katare, O.P.6
Raza, K.7
-
15
-
-
11944265265
-
Nanoparticle surface charges alter blood-brain barrier integrity and permeability
-
Lockman, P. R., Koziara, J. M., Mumper, R. J., and Allen, D. D. (2004) Nanoparticle surface charges alter blood-brain barrier integrity and permeability J. Drug Target. 12, 635-641 10.1080/10611860400015936
-
(2004)
J. Drug Target.
, vol.12
, pp. 635-641
-
-
Lockman, P.R.1
Koziara, J.M.2
Mumper, R.J.3
Allen, D.D.4
-
16
-
-
77950844756
-
Kinetic modeling on drug release from controlled drug delivery systems
-
Dash, S., Murthy, P. N., Nath, L., and Chowdhury, P. (2010) Kinetic modeling on drug release from controlled drug delivery systems Acta Polym. Pharm. 67, 217-223
-
(2010)
Acta Polym. Pharm.
, vol.67
, pp. 217-223
-
-
Dash, S.1
Murthy, P.N.2
Nath, L.3
Chowdhury, P.4
-
17
-
-
84921047168
-
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: An overview
-
Bomprezzi, R. (2015) Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview Ther. Adv. Neurol. Disord. 8, 20-30 10.1177/1756285614564152
-
(2015)
Ther. Adv. Neurol. Disord.
, vol.8
, pp. 20-30
-
-
Bomprezzi, R.1
-
18
-
-
84877276974
-
Nanocolloidal carriers of isotretinoin: Antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling
-
Raza, K., Singh, B., Singla, S., Wadhwa, S., Garg, B., Chhibber, S., and Katare, O. P. (2013) Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling Mol. Pharmaceutics 10, 1958-1963 10.1021/mp300722f
-
(2013)
Mol. Pharmaceutics
, vol.10
, pp. 1958-1963
-
-
Raza, K.1
Singh, B.2
Singla, S.3
Wadhwa, S.4
Garg, B.5
Chhibber, S.6
Katare, O.P.7
-
19
-
-
84899044311
-
Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity
-
Raza, K., Singh, B., Lohan, S., Sharma, G., Negi, P., Yachha, Y., and Katare, O. P. (2013) Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity Int. J. Pharm. 456, 65-72 10.1016/j.ijpharm.2013.08.019
-
(2013)
Int. J. Pharm.
, vol.456
, pp. 65-72
-
-
Raza, K.1
Singh, B.2
Lohan, S.3
Sharma, G.4
Negi, P.5
Yachha, Y.6
Katare, O.P.7
-
20
-
-
84973358463
-
Enhanced efficacy and a better pharmacokinetic profile of tamoxifen employing polymeric micelles
-
Yadav, H., Kumar, P., Sharma, V., Sharma, G., Raza, K., and Katare, O. P. (2016) Enhanced efficacy and a better pharmacokinetic profile of tamoxifen employing polymeric micelles RSC Adv. 6, 53351-53357 10.1039/C6RA10874A
-
(2016)
RSC Adv.
, vol.6
, pp. 53351-53357
-
-
Yadav, H.1
Kumar, P.2
Sharma, V.3
Sharma, G.4
Raza, K.5
Katare, O.P.6
-
21
-
-
80055067178
-
Determination of dimethyl fumarate in desiccant and antimould sachets by reversed-phase liquid chromatography
-
Gennari, O., Montesano, D., Salzano, A., Albrizio, S., and Grumetto, L. (2011) Determination of dimethyl fumarate in desiccant and antimould sachets by reversed-phase liquid chromatography Biomed. Chromatogr. 25, 1315-1318 10.1002/bmc.1602
-
(2011)
Biomed. Chromatogr.
, vol.25
, pp. 1315-1318
-
-
Gennari, O.1
Montesano, D.2
Salzano, A.3
Albrizio, S.4
Grumetto, L.5
-
22
-
-
85004093183
-
Biocompatible Phospholipid-based Mixed Micelles for Tamoxifen Delivery: Promising Evidences from In-vitro Anticancer Activity and Dermatokinetic Studies
-
Kumar, P., Kumar, R., Singh, B., Malik, R., Sharma, G., Chitkara, D., Katare, O. P., and Raza, K. (2016) Biocompatible Phospholipid-based Mixed Micelles for Tamoxifen Delivery: Promising Evidences from In-vitro Anticancer Activity and Dermatokinetic Studies AAPS PharmSciTech 10.1208/s12249-016-0681-1
-
(2016)
AAPS PharmSciTech
-
-
Kumar, P.1
Kumar, R.2
Singh, B.3
Malik, R.4
Sharma, G.5
Chitkara, D.6
Katare, O.P.7
Raza, K.8
-
23
-
-
85002526896
-
PLGA-Soya lecithin based Micelles for Enhanced Delivery of Methotrexate: Cellular Uptake, Cytotoxic and Pharmacokinetic Evidences
-
Singh, A., Thotakura, N., Kumar, R., Singh, B., Sharma, G., Katare, O. P., and Raza, K. (2017) PLGA-Soya lecithin based Micelles for Enhanced Delivery of Methotrexate: Cellular Uptake, Cytotoxic and Pharmacokinetic Evidences Int. J. Biol. Macromol. 95, 750-756 10.1016/j.ijbiomac.2016.11.111
-
(2017)
Int. J. Biol. Macromol.
, vol.95
, pp. 750-756
-
-
Singh, A.1
Thotakura, N.2
Kumar, R.3
Singh, B.4
Sharma, G.5
Katare, O.P.6
Raza, K.7
-
24
-
-
33748887871
-
Caco-2 cell permeability assays to measure drug absorption
-
Van Breemen, R. B. and Li, Y. (2005) Caco-2 cell permeability assays to measure drug absorption Expert Opin. Drug Metab. Toxicol. 1, 175-185 10.1517/17425255.1.2.175
-
(2005)
Expert Opin. Drug Metab. Toxicol.
, vol.1
, pp. 175-185
-
-
Van Breemen, R.B.1
Li, Y.2
-
25
-
-
77951240010
-
SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in Parkinson's disease
-
Xie, H. R., Hu, L. S., and Li, G. Y. (2010) SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in Parkinson's disease Chin. Med. J. 123, 1086-92
-
(2010)
Chin. Med. J.
, vol.123
, pp. 1086-1092
-
-
Xie, H.R.1
Hu, L.S.2
Li, G.Y.3
|